CoChat
Sign Up
Cited by 1,098

Siglec-mediated regulation of immune cell function in disease

Macauley, Matthew S., Crocker, Paul R., Paulson, James C.·2014·Nature Reviews Immunology
DOI 10.1038/nri3737PMC PMC4191907
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nri3737

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SIGLECs regulate the effects of activation, phagocytosis and inflammasome formation via their immunoreceptor tyrosine-based inhibition motif (ITIM).

    “SIGLECs regulate the effects of activation, phagocytosis and inflammasome formation via their immunoreceptor tyrosine-based inhibition motif (ITIM) 37 .”

    From Transcriptomic analysis of purified human cortical microglia reveals age-associated changes (2017) · cites this paper as [37]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 142

  1. [1]Crocker PR Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains The EMBO journal 13 4490 503 1994 7925291 PMC395382
  2. [2]Sgroi D Varki A Braesch-Andersen S Stamenkovic I CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin J Biol Chem 268 7011 8 1993 8463234
  3. [3]Crocker PR Paulson JC Varki A Siglecs and their roles in the immune system Nat Rev Immunol 7 255 66 2007 17380156
  4. [4]Cao H Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region Immunogenetics 61 401 17 2009 19337729
  5. [5]Ali SR Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus J Exp Med 211 1231 42 2014 24799499 PMC4042635
  6. [6]Cao H Crocker PR Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology 132 18 26 2011 21070233 PMC3015071
  7. [7]Angata T Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation Cell Mol Life Sci 70 3199 210 2013 23519826 PMC3718857
  8. [8]Cao H SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans Eur J Immunol 38 2303 15 2008 18629938
  9. [9]O’Reilly MK Tian H Paulson JC CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells J Immunol 186 1554 63 2011 21178016 PMC3024466
  10. [10]Delputte PL Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages PLoS One 6 e16827 2011 21359217 PMC3040196
  11. [11]Kawasaki N Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation Proc Natl Acad Sci U S A 110 7826 31 2013 23610394 PMC3651435
  12. [12]Stuible M Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption J Biol Chem 289 6498 512 2014 24446437 PMC3945315
  13. [13]Tateno H Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity Mol Cell Biol 27 5699 710 2007 17562860 PMC1952126
  14. [14]Walter RB ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2 J Leukoc Biol 83 200 11 2008 17947393
  15. [15]Winterstein C Trotter J Kramer-Albers EM Distinct endocytic recycling of myelin proteins promotes oligodendroglial membrane remodeling J Cell Sci 121 834 42 2008 18303048
  16. [16]Attrill H Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b J Biol Chem 281 32774 83 2006 16895906
  17. [17]May AP Robinson RC Vinson M Crocker PR Jones EY Crystal structure of the N-terminal domain of sialoadhesin in complex with 3′ sialyllactose at 1.85 A resolution Molecular cell 1 719 28 1998 9660955
  18. [18]Zhuravleva MA Trandem K Sun PD Structural implications of Siglec-5-mediated sialoglycan recognition J Mol Biol 375 437 47 2008 18022638 PMC2245879
  19. [20]Pillai S Cariappa A Pirnie SP Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance Trends Immunol 30 488 93 2009 19766537 PMC2758290
  20. [21]Klaas M Crocker PR Sialoadhesin in recognition of self and non-self Semin Immunopathol 34 353 64 2012 22450957
  21. [22]Paulson JC Macauley MS Kawasaki N Siglecs as sensors of self in innate and adaptive immune responses Ann N Y Acad Sci 1253 37 48 2012 22288608 PMC3335958
  22. [23]Padler-Karavani V Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates FASEB J 28 1280 93 2014 24308974 PMC3929681
  23. [24]Hutzler S The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells J Immunol 192 5406 14 2014 24790146
  24. [25]Muller J CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling Proc Natl Acad Sci U S A 110 12402 7 2013 23836650 PMC3725054
  25. [26]Muller J Nitschke L The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease Nat Rev Rheumatol 2014 24763061
  26. [27]Pillai S Netravali IA Cariappa A Mattoo H Siglecs and immune regulation Annu Rev Immunol 30 357 92 2012 22224769 PMC3781015
  27. [28]Poe JC Tedder TF CD22 and Siglec-G in B cell function and tolerance Trends Immunol 33 413 20 2012 22677186 PMC3407281
  28. [29]Kiwamoto T Katoh T Tiemeyer M Bochner BS The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation Curr Opin Allergy Clin Immunol 13 106 11 2013 23160308 PMC4376104
  29. [30]Chang YC Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo PLoS Pathog 10 e1003846 2014 24391502 PMC3879367
  30. [31]Chang YC Nizet V The interplay between Siglecs and sialylated pathogens Glycobiology 2014 PMC4168292 24996821
  31. [32]Chang YC Uchiyama S Varki A Nizet V Leukocyte inflammatory responses provoked by pneumococcal sialidase mBio 3 2012 PMC3251504 22215570
  32. [33]Chen GY Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction Nat Biotechnol 29 428 35 2011 21478876 PMC4090080
  33. [34]Chang YC Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus J Mol Med (Berl) 2014 PMC4133643 24788876
  34. [35]Klaas M Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni J Immunol 189 2414 22 2012 22851711 PMC3442253
  35. [36]Ando M Tu W Nishijima K Iijima S Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs Biochem Biophys Res Commun 369 878 83 2008 18325328
  36. [37]Boyd CR Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production J Immunol 183 7703 9 2009 19933851 PMC5580793
  37. [38]Ohta M Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9 Biochem Biophys Res Commun 402 663 9 2010 20971061
  38. [39]Miyazaki K Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9 J Immunol 188 4690 700 2012 22467657
  39. [41]Chen W Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation Cell 152 467 78 2013 23374343
  40. [42]Avril T Wagner ER Willison HJ Crocker PR Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides Infect Immun 74 4133 41 2006 16790787 PMC1489752
  41. [43]Stephenson HN Pseudaminic Acid on Campylobacter jejuni Flagella Modulates Dendritic Cell IL-10 Expression via Siglec-10 Receptor: A Novel Flagellin-Host Interaction J Infect Dis 2014 PMC4195440 24823621
  42. [45]Puryear WB Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169 PLoS Pathog 9 e1003291 2013 23593001 PMC3623718
  43. [46]Zou Z Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids PLoS One 6 e24559 2011 21931755 PMC3169630
  44. [47]Rosenberg HF Dyer KD Foster PS Eosinophils: changing perspectives in health and disease Nat Rev Immunol 13 9 22 2013 23154224 PMC4357492
  45. [48]Pappas K Papaioannou AI Kostikas K Tzanakis N The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma Cytokine 64 613 25 2013 24084332
  46. [49]Deckers J Branco Madeira F Hammad H Innate immune cells in asthma Trends Immunol 34 540 7 2013 24035576
  47. [50]Caramori G Pandit A Papi A Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease? Curr Opin Allergy Clin Immunol 5 77 83 2005 15643348
  48. [51]Barnes PJ Mediators of chronic obstructive pulmonary disease Pharmacol Rev 56 515 48 2004 15602009
  49. [52]Ilmarinen P Kankaanranta H Eosinophil apoptosis as a therapeutic target in allergic asthma Basic Clin Pharmacol Toxicol 114 109 17 2014 24148899
  50. [53]Kiwamoto T Kawasaki N Paulson JC Bochner BS Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions Pharmacol Ther 135 327 36 2012 22749793 PMC3587973
  51. [54]Floyd H Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily J Biol Chem 275 861 6 2000 10625619
  52. [55]Zhang JQ Biedermann B Nitschke L Crocker PR The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils Eur J Immunol 34 1175 84 2004 15048729
  53. [56]Tateno H Crocker PR Paulson JC Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6′-sulfo-sialyl Lewis X as a preferred glycan ligand Glycobiology 15 1125 35 2005 15972893
  54. [57]Gao PS Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma Eur J Hum Genet 18 713 9 2010 20087405 PMC2987348
  55. [58]Hudson SA Bovin NV Schnaar RL Crocker PR Bochner BS Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6′-sulfated sialyl Lewis x J Pharmacol Exp Ther 330 608 12 2009 19458105 PMC2713093
  56. [59]Nutku E Aizawa H Hudson SA Bochner BS Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis Blood 101 5014 20 2003 12609831
  57. [60]Nutku-Bilir E Hudson SA Bochner BS Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways Am J Respir Cell Mol Biol 38 121 4 2008 17690326 PMC2176128
  58. [61]Mao H Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen PLoS One 8 e68143 2013 23840825 PMC3695997
  59. [62]Kiwamoto T Mice deficient in the St3gal3 gene product alpha2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation J Allergy Clin Immunol 133 240 7 e1 3 2014 23830412 PMC3874253
  60. [63]Bochner BS Glycan array screening reveals a candidate ligand for Siglec-8 J Biol Chem 280 4307 12 2005 15563466
  61. [64]Patnode ML Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue J Biol Chem 288 26533 45 2013 23880769 PMC3772201
  62. [65]Guo JP Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs Am J Respir Cell Mol Biol 44 238 43 2011 20395633 PMC3049235
  63. [66]Zhang M Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils Blood 109 4280 7 2007 17272508 PMC1885492
  64. [67]Cho JY Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13 Respir Res 11 154 2010 21040544 PMC2988013
  65. [68]Suzukawa M Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice J Immunol 190 5939 48 2013 23677475 PMC3679360
  66. [69]McMillan SJ Richards HE Crocker PR Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model Immunol Lett 160 11 16 2014 24698729 PMC4045373
  67. [70]McMillan SJ Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b beta2-integrin-dependent signaling Blood 121 2084 94 2013 23315163 PMC3596968
  68. [71]McMillan SJ Sharma RS Richards HE Hegde V Crocker PR Siglec-E Promotes beta2-Integrin-dependent NADPH Oxidase Activation to Suppress Neutrophil Recruitment to the Lung J Biol Chem 289 20370 20376 2014 24895121 PMC4106349
  69. [72]Wang J Shiratori I Uehori J Ikawa M Arase H Neutrophil infiltration during inflammation is regulated by PILRalpha via modulation of integrin activation Nat Immunol 14 34 40 2013 23142774
  70. [73]Kettenmann H Hanisch UK Noda M Verkhratsky A Physiology of microglia Physiol Rev 91 461 553 2011 21527731
  71. [74]Griciuc A Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta Neuron 78 631 43 2013 23623698 PMC3706457
  72. [75]Malik M CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing J Neurosci 33 13320 5 2013 23946390 PMC3742922
  73. [77]Angata T Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia J Biol Chem 277 24466 74 2002 11986327
  74. [78]Linnartz-Gerlach B Kopatz J Neumann H Siglec functions of microglia Glycobiology 2014 24833613
  75. [80]Hollingworth P Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease Nat Genet 43 429 35 2011 21460840 PMC3084173
  76. [81]Bertram L Genome-wide association analysis reveals putative Alzheimer’s disease susceptibility loci in addition to APOE Am J Hum Genet 83 623 32 2008 18976728 PMC2668052
  77. [83]Goodnow CC Sprent J Fazekas de St Groth B Vinuesa CG Cellular and genetic mechanisms of self tolerance and autoimmunity Nature 435 590 7 2005 15931211
  78. [84]Basten A Silveira PA B-cell tolerance: mechanisms and implications Curr Opin Immunol 22 566 74 2010 20829011
  79. [85]Jellusova J Wellmann U Amann K Winkler TH Nitschke L CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity J Immunol 184 3618 27 2010 20200274
  80. [86]Bokers S Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice J Immunol 192 2994 3002 2014 24600033
  81. [87]Razi N Varki A Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes Proc Natl Acad Sci U S A 95 7469 74 1998 9636173 PMC22653
  82. [88]Collins BE Smith BA Bengtson P Paulson JC Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling Nat Immunol 7 199 206 2006 16369536
  83. [89]Grewal PK ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling Mol Cell Biol 26 4970 81 2006 16782884 PMC1489171
  84. [90]Surolia I Functionally defective germline variants of sialic acid acetylesterase in autoimmunity Nature 466 243 7 2010 20555325 PMC2900412
  85. [91]Naito Y Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation Mol Cell Biol 27 3008 22 2007 17296732 PMC1899932
  86. [92]Cariappa A B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase J Exp Med 206 125 38 2009 19103880 PMC2626685
  87. [93]Kimura N Human B-lymphocytes express alpha2–6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2 J Biol Chem 282 32200 7 2007 17728258
  88. [94]Collins BE Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact Proc Natl Acad Sci U S A 101 6104 9 2004 15079087 PMC395930
  89. [95]Lanoue A Batista FD Stewart M Neuberger MS Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur J Immunol 32 348 55 2002 11807774
  90. [96]Lee M Transcriptional programs define specialization of lymphoid tissue capillary and high endothelium and reveal novel trafficking mechanisms Nat Immunol in press 2014 PMC4222088 25173345
  91. [97]Duong BH Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo J Exp Med 207 173 87 2010 20038598 PMC2812539
  92. [98]Pfrengle F Macauley MS Kawasaki N Paulson JC Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22 J Immunol 191 1724 31 2013 23836061 PMC3735655
  93. [99]Macauley MS Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis J Clin Invest 123 3074 83 2013 23722906 PMC3706185
  94. [100]Courtney AH Puffer EB Pontrello JK Yang ZQ Kiessling LL Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation Proc Natl Acad Sci U S A 106 2500 5 2009 19202057 PMC2650292
  95. [101]Adachi T CD22 serves as a receptor for soluble IgM Eur J Immunol 42 241 7 2012 21956693
  96. [102]Wu C Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression J Immunol 182 6508 16 2009 19414805 PMC3733067
  97. [103]Kidder D Richards HE Ziltener HJ Garden OA Crocker PR Sialoadhesin ligand expression identifies a subset of CD4+Foxp3- T cells with a distinct activation and glycosylation profile J Immunol 190 2593 602 2013 23408841 PMC3586974
  98. [104]Bandala-Sanchez E T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10 Nat Immunol 14 741 8 2013 23685786
  99. [105]Ricart AD Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin Clin Cancer Res 17 6417 27 2011 22003069
  100. [106]Sullivan-Chang L O’Donnell RT Tuscano JM Targeting CD22 in B-cell malignancies: current status and clinical outlook BioDrugs 27 293 304 2013 23696252
  101. [107]Uckun FM Goodman P Ma H Dibirdik I Qazi S CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia Proc Natl Acad Sci U S A 107 16852 7 2010 20841423 PMC2947921
  102. [108]Simonetti G SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders Haematologica 2014 PMC4116835 24859880
  103. [109]Fuster MM Esko JD The sweet and sour of cancer: glycans as novel therapeutic targets Nat Rev Cancer 5 526 42 2005 16069816
  104. [110]Kumar V McNerney ME A new self: MHC-class-I-independent natural-killer-cell self-tolerance Nat Rev Immunol 5 363 74 2005 15841099
  105. [111]Jandus C Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance J Clin Invest 124 1810 20 2014 24569453 PMC3973073
  106. [112]Hudak JE Canham SM Bertozzi CR Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion Nat Chem Biol 10 69 75 2014 24292068 PMC3893890
  107. [113]Nicoll G Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms Eur J Immunol 33 1642 8 2003 12778482
  108. [114]Belisle JA Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes Mol Cancer 9 118 2010 20497550 PMC2890604
  109. [115]Toda M Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells Biochem J 417 673 83 2009 18925876
  110. [116]O’Reilly MK Paulson JC Siglecs as targets for therapy in immune-cell-mediated disease Trends Pharmacol Sci 30 240 8 2009 19359050 PMC2830709
  111. [117]Chen WC In vivo targeting of B-cell lymphoma with glycan ligands of CD22 Blood 115 4778 86 2010 20181615 PMC2890185
  112. [118]Chen WC Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169 PLoS One 7 e39039 2012 22723922 PMC3378521
  113. [119]Ravandi F Gemtuzumab ozogamicin: time to resurrect? J Clin Oncol 30 3921 3 2012 22987091 PMC4874205
  114. [120]Mims A Stuart RK Developmental therapeutics in acute myelogenous leukemia: are there any new effective cytotoxic chemotherapeutic agents out there? Curr Hematol Malig Rep 8 156 62 2013 23640069
  115. [121]Farid S Mirshafiey A Razavi A Siglec-8 and Siglec-F, the new therapeutic targets in asthma Immunopharmacol Immunotoxicol 34 721 6 2012 22324980
  116. [122]Zimmermann N Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils Allergy 63 1156 63 2008 18699932 PMC2726770
  117. [123]Kim YH Antiallergic effect of anti-Siglec-F through reduction of eosinophilic inflammation in murine allergic rhinitis Am J Rhinol Allergy 27 187 91 2013 23710953
  118. [124]Rubinstein E Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis J Pediatr Gastroenterol Nutr 53 409 16 2011 21970996 PMC3980963
  119. [125]Song DJ Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling J Immunol 183 5333 41 2009 19783675 PMC2788790
  120. [126]Chen WC Sigal DS Saven A Paulson JC Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22 Leuk Lymphoma 53 208 10 2012 21756025 PMC3197974
  121. [127]Ooms K Evaluation of viral peptide targeting to porcine sialoadhesin using a porcine reproductive and respiratory syndrome virus vaccination-challenge model Virus Res 177 147 55 2013 23932898
  122. [128]Kawasaki N Rademacher C Paulson JC CD22 regulates adaptive and innate immune responses of B cells J Innate Immun 3 411 9 2011 21178327 PMC3130896
  123. [129]Teitelbaum SL Bone resorption by osteoclasts Science 289 1504 8 2000 10968780
  124. [130]Udagawa N Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells Proc Natl Acad Sci U S A 87 7260 4 1990 2169622 PMC54723
  125. [131]Angata T Tabuchi Y Nakamura K Nakamura M Siglec-15: an immune system Siglec conserved throughout vertebrate evolution Glycobiology 17 838 46 2007 17483134
  126. [132]Hiruma Y Hirai T Tsuda E Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation Biochem Biophys Res Commun 409 424 429 2011 21586272
  127. [133]Ishida-Kitagawa N Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12) J Biol Chem 287 17493 502 2012 22451653 PMC3366812
  128. [134]Hiruma Y Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice Bone 53 87 93 2013 23238125
  129. [135]Kameda Y Siglec-15 Regulates Osteoclast Differentiation by Modulating RANKL-Induced Phosphatidylinositol 3-Kinase/Akt and Erk Pathways in Association With Signaling Adaptor DAP12 J Bone Miner Res 28 2463 75 2013 23677868
  130. [136]Silva-Fernandez L Rosario MP Martinez-Lopez JA Carmona L Loza E Denosumab for the treatment of osteoporosis: a systematic literature review Reumatol Clin 9 42 52 2013 22947600
  131. [137]Blixt O Collins BE van den Nieuwenhof IM Crocker PR Paulson JC Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein J Biol Chem 278 31007 19 2003 12773526
  132. [138]Brinkman-Van der Linden EC Varki A New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins J Biol Chem 275 8625 32 2000 10722702
  133. [139]Angata T Hayakawa T Yamanaka M Varki A Nakamura M Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates FASEB J 20 1964 73 2006 17012248
  134. [140]Brinkman-Van der Linden EC Human-specific expression of Siglec-6 in the placenta Glycobiology 17 922 31 2007 17580316
  135. [141]Lunnon K Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration J Immunol 186 7215 24 2011 21572034
  136. [142]Munday J Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor Biochem J 355 489 97 2001 11284738 PMC1221762
  137. [143]Toubai T Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice Blood 2014 PMC4041170 24695850
  138. [144]Blasius AL Cella M Maldonado J Takai T Colonna M Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12 Blood 107 2474 6 2006 16293595 PMC1895736
  139. [145]Puttur F Absence of Siglec-H in MCMV infection elevates interferon alpha production but does not enhance viral clearance PLoS Pathog 9 e1003648 2013 24086137 PMC3784486
  140. [146]Zhang J Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors Blood 107 3600 8 2006 16397130
  141. [147]Mitra N SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas J Biol Chem 286 23003 11 2011 21555517 PMC3123068
  142. [148]Wang X Specific inactivation of two immunomodulatory SIGLEC genes during human evolution Proc Natl Acad Sci U S A 109 9935 40 2012 22665810 PMC3382539

Cited by

Sorted by citations

Authors
Macauley, M. S., Crocker, P. R., & Paulson, J. C.
Venue
Nature Reviews Immunology
Publisher
Springer Science and Business Media LLC
Published
2014-09-19
Volume
14
Issue
10
Pages
653-666
ISSN
  • 1474-1733
  • 1474-1741
DOI
10.1038/nri3737
PMC
PMC4191907
Cited by
1,098
References
6
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review